Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

14.4K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
14.4K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

9.8K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
9.8K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.2K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.2K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

432
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
432
Coagulation01:09

Coagulation

11.5K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
11.5K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

10.2K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
10.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identifying risk factors for venous thromboembolism in medical inpatients: a systematic review and meta-analysis.

Research and practice in thrombosis and haemostasis·2026
Same author

Revascularization in Acute Myocardial Infarction and Cardiogenic Shock in the Era of Mechanical Circulatory Support.

Interventional cardiology clinics·2026
Same author

<sup>18</sup>F-NaF and <sup>18</sup>F-FDG PET/CT imaging of spinal instrumentation: case report and review of the literature.

American journal of nuclear medicine and molecular imaging·2026
Same author

Controversies in thromboprophylaxis: a focus on nonsurgical patients.

Journal of thrombosis and haemostasis : JTH·2026
Same author

Addressing learning gaps to improve access to assisted reproductive technology in low-resource settings: Development and evaluation of a low-cost oocyte retrieval simulator.

African journal of reproductive health·2026
Same author

Comparative safety of oral anticoagulants in severe renal impairment.

Research and practice in thrombosis and haemostasis·2026
Same journal

Real-World Evidence Assessment of the Risk of Nonfatal Stroke in Patients Prescribed SGLT2 Inhibitors.

Stroke research and treatment·2026
Same journal

An Intensive and Comprehensive Aphasia Program Versus a Conventional Speech and Language Therapy: A Dose-Controlled, Crossover Experimental Study.

Stroke research and treatment·2026
Same journal

Ticagrelor Versus Clopidogrel or Aspirin in Secondary Stroke Prevention: Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Stroke research and treatment·2026
Same journal

Influence of Trunk Function on Assisted Gait and Independence in Patients With Acute Stroke.

Stroke research and treatment·2026
Same journal

Troponin Elevation Is a Potential Marker for Patients With Acute Ischemic Stroke in Intensive Care Units: A Retrospective Observational Study.

Stroke research and treatment·2026
Same journal

Association Between TSH Level and Stroke Severity: A Cross-Sectional Study Using the mRS.

Stroke research and treatment·2026
See all related articles

Related Experiment Video

Updated: Mar 8, 2026

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

3.6K

Thrombin Generation in Acute Ischaemic Stroke.

Ibrahim O Balogun1, Lara N Roberts2, Raj Patel2

  • 1King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK; Department of Stroke Medicine, East Kent Hospitals University NHS Foundation Trust, East Kent, UK.

Stroke Research and Treatment
|January 25, 2017
PubMed
Summary
This summary is machine-generated.

Thrombin generation assays did not identify hypercoagulability in acute ischemic stroke patients. This finding contrasts with other hypercoagulable states, suggesting limitations in this method for stroke assessment.

More Related Videos

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

15.6K
Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models
06:16

Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models

Published on: April 19, 2024

1.9K

Related Experiment Videos

Last Updated: Mar 8, 2026

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

3.6K
A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

15.6K
Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models
06:16

Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models

Published on: April 19, 2024

1.9K

Area of Science:

  • Cardiovascular Science
  • Hematology
  • Neurology

Background:

  • Stroke is a leading cause of death and disability worldwide.
  • Traditional views suggest hypercoagulability post-stroke due to plasma and endothelial factors.
  • No single assay currently measures global coagulation comprehensively.

Purpose of the Study:

  • To investigate coagulation abnormalities in acute ischemic stroke using thrombin generation.
  • To assess if thrombin generation can identify hypercoagulable states in stroke patients.
  • To compare thrombin generation profiles between different stroke etiologies and healthy controls.

Main Methods:

  • Calibrated automated thrombography was used to measure thrombin generation.
  • Evaluated 170 stroke patients within 48 hours (baseline) and in the second week.
  • Compared stroke patients with 71 healthy volunteers.

Main Results:

  • Cardioembolic stroke showed prolonged lag time and time to peak compared to non-cardioembolic stroke.
  • These differences were observed at baseline and in the second week post-stroke.
  • Endogenous thrombin potential and peak thrombin did not indicate hypercoagulability; thrombolytic therapy had no effect.

Conclusions:

  • Thrombin generation in platelet-poor plasma is not a reliable indicator of hypercoagulability in acute ischemic stroke.
  • Findings align with trends seen in coronary artery disease.
  • This method may not be suitable for defining hypercoagulable states in stroke patients.